Recombinant human CLEC2L protein; Source: E. coli derived, PGEX-4T; Tag: GST; Domain: 90-214 aa of NM_001080511.2
Conjugate
Unconjugated
Applications
Application Notes
WB: 1:1000-1:4000 IHC: 1:50-1:500
General Notes
This product (Catalog No. DPABH-22773) is a rabbit-derived polyclonal antibody raised against human CLEC2L, targeting the amino acid region 90–214 of the protein. This antibody exhibits cross-reactivity with Human CLEC2L from mouse and rat. It has been affinity purified by Protein A. C-type lectin domain family 2 member L (CLEC2L) is a membrane protein mainly expressed in brain tissue and probably has carbohydrate-binding activity. The CLEC2L-encoded C-type lectin-like receptors (CTLRs) are expressed as non-glycosylated, disulfide-linked homodimers at the cell surface, and designated as BACL (brain-associated C-type lectin) (PMID: 23776472). The CLEC2L protein has 214 amino acids with a predicted molecular mass of 23.9 kDa. Under non-reducing conditions, FLAG-tagged CLEC2L proteins appeared with a molecular mass of ~55 kDa in immunoblots because of the occurrence of disulfide-linked homodimers (PMID: 23776472). DPABH-22773 is suitable for use in Western blot (WB) (1:1,000–1:4,000), IHC (1:50–1:500) applications. DPABH-22773 is supplied as a liquid formulation in PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. For long-term storage, keep at −20 °C. For short-term use, store at 2–8 °C. Avoid repeated freeze–thaw cycles to maintain antibody integrity and performance.
Target
Alternative Names
C-type lectin domain family 2 member L; C-Type Lectin Domain Family 2; Member L
My Review for Rabbit Anti-Human CLEC2L (a.a. 90-214) Polyclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.